MetaVia (MTVA)
1.58
0.00 (0.00%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on MetaVia (MTVA)
July 10, 2026 6:50 AM - StreetInsider
Form 8-K MetaVia Inc. For: Jul 09
July 9, 2026 8:36 AM - SEC Filing
MetaVia completes dose titration in Phase 1 Part 3 obesity trial
July 9, 2026 8:31 AM - StreetInsider
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
July 9, 2026 8:31 AM - PR NewsWire
Form 8-K MetaVia Inc. For: Jul 02
July 2, 2026 4:07 PM - SEC Filing
Form 424B5 MetaVia Inc.
July 2, 2026 4:05 PM - SEC Filing
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026 8:35 AM - StreetInsider
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - Globe NewsWire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - StreetInsider
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
June 17, 2026 8:31 AM - PR NewsWire
Presenting on Emerging Growth Conference 93 Day 2 on June 11; Register to live stream
June 10, 2026 7:00 AM - Globe NewsWire
BioStem Technologies appoints three new board members
June 9, 2026 7:00 AM - StreetInsider
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
June 9, 2026 7:00 AM - Globe NewsWire
Form 4 MetaVia Inc. For: Jun 08 Filed by: Tursi James Patrick
June 8, 2026 6:34 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: STRICKLAND D GORDON
June 8, 2026 6:33 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: Salsbury Michael
June 8, 2026 6:32 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: GROVES JASON L
June 8, 2026 6:31 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: KOVEN ANDREW I
June 8, 2026 6:31 PM - SEC Filing
Form 4 MetaVia Inc. For: Jun 08 Filed by: Glickman Mark A
June 8, 2026 6:29 PM - SEC Filing
Form S-8 MetaVia Inc.
June 8, 2026 4:31 PM - SEC Filing
MetaVia stockholders approve reverse stock split, equity plan expansion
June 8, 2026 4:04 PM - StreetInsider
Form 8-K MetaVia Inc. For: Jun 08
June 8, 2026 4:01 PM - SEC Filing
Form 8-K MetaVia Inc. For: Jun 08
June 8, 2026 9:02 AM - SEC Filing
MetaVia reports obesity drug achieves 9.1% weight loss in phase 1 study
June 8, 2026 8:32 AM - StreetInsider
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
June 8, 2026 8:31 AM - PR NewsWire
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference
June 4, 2026 8:31 AM - PR NewsWire
Form 8-K MetaVia Inc. For: May 27
May 27, 2026 9:01 AM - SEC Filing
MetaVia reports 9.1% weight loss in obesity drug trial
May 27, 2026 8:31 AM - StreetInsider
MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH
May 27, 2026 8:31 AM - PR NewsWire
MetaVia announces peer-reviewed study on vanoglipel for liver fibrosis
May 20, 2026 8:02 AM - StreetInsider
MetaVia Highlights Peer-Reviewed Publication Supporting the Anti-Fibrotic Potential of Vanoglipel in MASH
May 20, 2026 8:00 AM - PR NewsWire
Form 8-K MetaVia Inc. For: May 18
May 18, 2026 9:01 AM - SEC Filing
MetaVia to Present Obesity Data at the American Diabetes Association's (ADA) 2026 Scientific Sessions
May 18, 2026 8:31 AM - PR NewsWire
Form SCHEDULE 13G MetaVia Inc. Filed by: Alyeska Investment Group, L.P.
May 15, 2026 4:45 PM - SEC Filing
Form 10-Q MetaVia Inc. For: Mar 31
May 14, 2026 4:09 PM - SEC Filing
Form 8-K MetaVia Inc. For: May 14
May 14, 2026 4:07 PM - SEC Filing
MetaVia Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026 4:05 PM - PR NewsWire
Form 8-K MetaVia Inc. For: May 11
May 11, 2026 9:01 AM - SEC Filing
MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026
May 11, 2026 8:31 AM - PR NewsWire
Form ARS MetaVia Inc. For: Dec 31
April 27, 2026 6:06 AM - SEC Filing
Form DEF 14A MetaVia Inc. For: Jun 08
April 27, 2026 6:04 AM - SEC Filing
Full Article List
